09/2009 - Državni zavod za intelektualno vlasništvo

HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 16, 2009, 9, 3373 – 3601 3565
Podnositelj europske MKP Broj objave europske Naziv izuma
prijave patenta
prijave patenta
(71) (51) (97) (54)
Teva Pharmaceutical Industries Ltd., IL A01N 1/02 (2006.01)
EP 2099290 * METHOD OF GENERATION AND EXPANSION OF
TISSUE-PROGENITOR CELLS AND MATURE TISSUE
CELLS FROM INTACT BONE MARROW OR INTACT
UMBILICAL CORD TISSUE
The European Molecular Biology
Laboratory, DE
EP 2091929 *
C07D 295/20 (2006.01)
C07C 275/44 (2006.01)
C07C 335/08 (2006.01)
C07C 335/16 (2006.01)
C07D 471/10 (2006.01)
C07D 215/40 (2006.01)
C07D 317/66 (2006.01)
C07D 217/06 (2006.01)
C07D 471/04 (2006.01)
C07D 211/52 (2006.01)
C07D 307/68 (2006.01)
C07D 243/08 (2006.01)
C07C 335/12 (2006.01)
C07C 335/14 (2006.01)
C07D 413/04 (2006.01)
The North Carolina State University, US C10G 3/00 (2006.01)
C10L 1/04 (2006.01)
C10L 1/06 (2006.01)
C10L 1/08 (2006.01)
C07C 1/22 (2006.01)
C10G 45/58 (2006.01)
C10G 45/68 (2006.01)
C10G 47/00 (2006.01)
C07C 1/24 (2006.01)
C11C 1/04 (2006.01)
The Regents of the University of
Michigan, US
The Royal Institution for the
Advancement of Learning/McGill
University, CA
THE TEXAS A & M UNIVERSITY
SYSTEM, US
C12Q 1/68 (2006.01)
G01N 33/53 (2006.01)
A61K 38/12 (2006.01)
A61K 31/138 (2006.01)
C07K 14/705 (2006.01)
C07K 16/00 (2006.01)
C07K 16/28 (2006.01)
C07H 21/04 (2006.01)
C12P 21/02 (2006.01)
C12N 5/06 (2006.01)
A61K 38/00 (2006.01)
A61K 39/00 (2006.01)
A61K 48/00 (2006.01)
The Trustees of the University of
Pennsylvania, US
The University of Tokyo, JP C07F 5/02 (2006.01)
G01N 21/64 (2006.01)
G01N 21/78 (2006.01)
THE WALTER AND ELIZA HALL C07D 239/94 (2006.01)
INSTITUTE OF MEDICAL RESEARCH, A61K 31/517 (2006.01)
AU
A61P 43/00 (2006.01)
Therapy Products, Inc. DBA Erchonia H01Q 1/24 (2006.01)
Medical, US
Tianjin Hemey Bio-Tech Co., Ltd., CN C07D 495/04 (2006.01)
C07D 487/04 (2006.01)
A61K 31/4365 (2006.01)
A61K 31/437 (2006.01)
A61P 35/00 (2006.01)
A61P 31/00 (2006.01)
A61P 37/00 (2006.01)
A61P 9/00 (2006.01)
A61P 9/10 (2006.01)
A61P 5/00 (2006.01)
Tibotec Pharmaceuticals Ltd., IE C07D 307/20 (2006.01)
C07D 493/04 (2006.01)
Tibotec Pharmaceuticals Ltd., IE A61K 31/506 (2006.01)
A61P 31/14 (2006.01)
Tibotec Pharmaceuticals Ltd., IE C07D 401/12 (2006.01)
C07D 491/04 (2006.01)
A61K 31/4709 (2006.01)
A61K 31/4741 (2006.01)
A61P 31/14 (2006.01)
Tigenix N.V., BE A61K 49/00 (2006.01)
TLD (Canada) Inc., CA B64F 1/32 (2006.01)
B66F 9/12 (2006.01)
Tontarelli, Sergio, IT B65D 6/18 (2006.01)
B65D 21/02 (2006.01)
EP 2097496 *
EP 2094866 *
EP 2099468 *
EP 2094726 *
EP 2086591 *
EP 2098529 *
EP 2094672 *
EP 2047559 *
EP 2093228 *
EP 2089371 *
EP 2097084 *
EP 2097402 *
EP 2094310 *
EP 2094566 *
EP 2091827 *
AGENTS THAT DISRUPT CELLULAR REPLICATION
AND THEIR USE IN INHIBITING PATHOLOGICAL
CONDITIONS
PROCESS FOR CONVERSION OF BIOMASS TO
FUEL
DIAGNOSIS AND TREATMENT OF BREAST CANCER
METHODS OF USE OF TRK RECEPTOR
MODULATORS
COMPOSITIONS AND METHODS RELATED TO
TOLL-LIKE RECEPTOR-3
EFFICIENT NUCLEAR DELIVERY OF ANTISENSE
OLIGONUCLEOTIDES
PH-SENSITIVE FLUORESCENT PROBE
ARYLSULFONAMIDE COMPOUNDS
METHOD AND DEVICE FOR REDUCING EXPOSURE
TO UNDESIRABLE ELECTROMAGNETIC RADIATION
PYRROLINE-2-ONE DERIVATIVES AGAINST CELL
RELEASING TUMOR NECROSIS FACTOR,
PREPARATION METHODS AND USES THEREOF
METHODS FOR THE PREPARATION OF
HEXAHYDROFUROÝ2,3-B¨FURAN-3-OL
CARBOXAMIDE 4-[(4-PYRIDYL)AMINO] PYRIMIDINES
FOR THE TREATMENT OF HEPATITIS C
MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS
MARKER GENES FOR USE IN THE IDENTIFICATION
OF CHONDROCYTE PHENOTYPIC STABILITY AND
IN THE SCREENING OF FACTORS INFLUENCING
CARTILAGE PRODUCTION
BARRIER SYSTEM FOR AN AIRCRAFT LOADER
BOX WITH COLLAPSIBLE WALLS DESIGNED TO
STACK A CORRESPONDING BOX WITH LOWER
DIMENSIONS
ISSN 1331-2030